LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations

Publisher： John Wiley & Sons Inc

E-ISSN： 1463-1326|17|5|477-486

ISSN： 1462-8902

Source： DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.17, Iss.5, 2015-05, pp. : 477-486

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclical relationship between depressive symptoms and diabetes distress in people with Type 2 diabetes mellitus: results from the Montreal Evaluation of Diabetes Treatment Cohort Study

By  

DIABETIC MEDICINE, Vol. 742-3071, Iss. 10, 2015-10 ,pp. : 1272-1278

John Wiley & Sons Inc

Access to resources Recommend Favorite

Normal pregnancy outcome after first‐trimester exposure to liraglutide in a woman with Type 2 diabetes

By  

DIABETIC MEDICINE, Vol. 742-3071, Iss. 10, 2015-10 ,pp. : e29-e30

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of liraglutide compared to sulphonylurea during Ramadan in patients with type 2 diabetes (LIRA‐Ramadan): a randomized trial

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 18, Iss. 10, 2016-10 ,pp. : 1025-1033

John Wiley & Sons Inc

Access to resources Recommend Favorite

One‐year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26‐week extension to a 26‐week main trial

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 10, 2015-10 ,pp. : 965-973

John Wiley & Sons Inc

Access to resources Recommend Favorite

One‐year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26‐week extension to a 26‐week main trial

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 1462-8902, Iss. 10, 2015-10 ,pp. : 965-973

John Wiley & Sons Inc

Access to resources Recommend Favorite